LC-MS/MS in the clinical laboratory - Where to from here?

Clinical Biochemist Reviews

Volumn 32, Issue 1, 2011, Pages 5-31

  Grebe, Stefan K G ^a   Singh, Ravinder J ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052539443     PISSN: 01598090     EISSN: 18380212     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Thomson JJ. On the Cathode Rays. Proc Camb Philos Soc 1897;9:243-4.
2. Thomson JJ. Rays of positive electricity. Proc Royal Soc London A 1913;A89:1-20.
3. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
4. Want EJ, Cravatt BF, Siuzdak G. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 2005;6:1941-51.
5. Scripps-Center. What is mass spectrometry? http://masspec.scripps.edu/mshistory/whatisms_toc.php (Accessed 6 December 2010).
6. Hammett-Stabler CA, Garg U. The evolution of mass spectrometry in the clinical laboratory. Methods Mol Biol 2010;603:1-7.7.
7. Rinaldo P, Tortorelli S, Matern D. Recent developments and new applications of tandem mass spectrometry in newborn screening. Curr Opin Pediatr 2004;16:427-33.
8. Kushnir MM, Rockwood AL, Bergquist J. Liquid chromatography-tandem mass spectrometry applications in endocrinology. Mass Spectrom Rev 2010;29:480-502.9.
9. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002;48:691-8.
10. Hoofnagle AN. Peptide lost and found: internal standards and the mass spectrometric quantification of peptides. Clin Chem 2010;56:1515-7.
11. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. Clin Chem Lab Med 2009;47:143-53.
12. Breuer H, Siekmann L. Mass fragmentography as reference method in clinical steroid assay. J Steroid Biochem 1975;6:685-8.
13. Nicolis GL, Gabrilove JL. Measurement of plasma aldosterone by gas chromatography with electron capture detection. J Clin Endocrinol Metab 1969;29:1519-25.
14. Stöckl D, Reinauer H, Thienpont LM, De Leenheer AP. Determination of aldosterone in human serum by isotope dilution gas chromatography/mass spectrometry using a new heptafluorobutyryl derivative. Biol Mass Spectrom 1991;20:657-64.
15. Taylor R, Singh R, Grebe S. Serum and urine aldosterone by LC-MS/MS with an automated off-line extraction [Abstract C-69]. Clin Chem 2006;52(Suppl 6):A100-1.
16. Taylor PJ, Cooper DP, Gordon RD, Stowasser M. Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem 2009;55:1155-62.
17. Taylor PJ, van Rosendal SP, Coombes JS, Gordon RD, Stowasser M. Simultaneous measurement of aldosterone and cortisol by high-performance liquid chromatography-tandem mass spectrometry: application to dehydration-rehydration studies. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1195-8.
18. Pearson Murphy BE. Lack of specificity of urinary free cortisol determinations: why does it continue? J Clin Endocrinol Metab 1999;84:2258-9.
19. Pearson Murphy, BE. Commercial radioimmunoassays do not measure urinary free cortisol accurately and should not be used for physiological studies. J Clin Endocrinol Metab 2003;88:4003.
20. Wood L, Ducroq DH, Fraser HL, Gillingwater S, Evans C, Pickett AJ, et al. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann Clin Biochem 2008;45:380-8.
21. Ching SYL, Lim EM, Beilby J, Bhagat C, Rossi E, Walsh JP, et al. Urine free cortisol analysis by automated immunoassay and high-performance liquid chromatography for the investigation of Cushing's syndrome. Ann Clin Biochem 2006;43:402-7.
22. Hirota N, Furuta T, Kasuya Y. Determination of cortisol in human plasma by capillary gas chromatographymass spectrometry using [2H5] cortisol as an internal standard. J Chromatogr 1988;425:237-43.
23. Kasuya Y, Furuta T, Hirota N. Determination of cortisol in human plasma by stable isotope dilution mass spectrometry. Biomed Environ Mass Spectrom 1988;16:309-11.
24. Taylor RL, Machacek D, Singh RJ. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem 2002;48:1511-9.
25. Kushnir MM, Rockwood AL, Nelson GJ, Terry AH, Meikle AW. Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol. Clin Chem 2003;49:965-7.
26. Meikle AW, Findling J, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH. Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab 2003;88:3521-4.
27. Santen RJ, Demers L, Ohorodnik S, Settlage J, Langecker P, Blanchett D, et al. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids 2007;72:666-728.
28. Santen RJ, Lee JS, Wang S, Demers LM, Mauras N, Wang H, et al. Potential role ofultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures. Steroids 2008;73:1318-21.
29. Soldin SJ, Soldin OP. Steroid hormone analysis by tandem mass spectrometry. Clin Chem 2009;55:1061-6.
30. Anari MR, Bakhtiar R, Zhu B, Huskey S, Franklin RB, Evans DC. Derivatization of ethinylestradiol with dansyl chloride to enhance electrospray ionization: application in trace analysis of ethinylestradiol in rhesus monkey plasma. Anal Chem 2002;74:4136-44.
31. Nelson RE, Grebe SK, O'Kane DJ, Singh RJ. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 2004;50:373-84.
32. Guo T, Gu J, Soldin OP, Singh RJ, Soldin SJ. Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography-tandem mass spectrometry without derivatization. Clin Biochem 2008;41:736-41.
33. Guo T, Taylor RL, Singh RJ, Soldin SJ. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 2006;372:76-82.
34. Rosner W, Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab 2010;95:4542-8.
35. Vesper HW, Botelho JC. Standardization of testosterone measurements in humans. J Steroid Biochem Mol Biol 2010;121:513-9.
36. Vesper HW, Botelho JC, Shacklady C, Smith A, Myers GL. CDC project on standardizing steroid hormone measurements. Steroids 2008;73:1286-92.
37. Kushnir MM, Blamires T, Rockwood AL, et al. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem 2010;56:1138-47.
38. Singh RJ. Validation of a high throughput method for serum/plasma testosterone using liquid chromatography tandem mass spectrometry (LC-MS/MS). Steroids 2008;73:1339-44.
39. Wudy SA, Hartmann M, Svoboda M. Determination of 17-hydroxyprogesterone in plasma by stable isotope dilution/benchtop liquid chromatography-tandem mass spectrometry. Horm Res 2000;53:68-71.
40. Eisenhofer G. Free or total metanephrines for diagnosis of pheochromocytoma: what is the difference? Clin Chem 2001;47:988-9.
41. Crockett DK, Frank EL, Roberts WL. Rapid analysis of metanephrine and normetanephrine in urine by gas chromatography-mass spectrometry. Clin Chem 2002;48:332-7.
42. Taylor RL, Singh RJ. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem 2002;48:533-9.
43. de Jong WHA, de Vries EGE, Wolffenbuttel BHR, Kema IP. Automated mass spectrometric analysis of urinary free catecholamines using on-line solid phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1506-12.
44. de Jong WHA, Graham KS, van der Molen JC, Links TP, Morris MR, Ross HA, et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin Chem 2007;53:1684-93.
45. Marney LC, Laha TJ, Baird GS, Rainey PM, Hoofnagle AN. Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatographytandem mass spectrometry. Clin Chem 2008;54: 1729-32.
46. Jones G. Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography. Clin Chem 1978;24:287-98.
47. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004;89:3152-7.
48. Singh RJ. Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D? Clin Chem 2008;54:221-3.
49. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 2008;88:511S-512S.
50. Tai SSC, Bedner M, Phinney KW. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 2010;82:1942-8.
51. Singh RJ, Taylor RL, Reddy GS, Grebe SKG. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006;91:3055-61.
52. Berna MJ, Ackermann BL, Murphy AT. High-throughput chromatographic approaches to liquid chromatographic/tandem mass spectrometric bioanalysis to support drug discovery and development. Anal Chim Acta 2004;509:1-9.
53. Jemal M. High-throughput quantitative bioanalysis by LC/MS/MS. Biomed Chromatogr 2000;14:422-9.
54. Wu J-T. The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for highthroughout screening of drug candidates in biological fluids. Rapid Commun Mass Spectrom 2001;15:73-81.
55. Xu RN, Fan L, Rieser MJ, El-Shourbagy TA. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J Pharm Biomed Anal 2007;44:342-55.
56. Netzel BC, Cradic KW, Bro ET, Girtman AB, Cyr RC, Singh RJ, et al. Increasing LC-MS/MS throughput by mass tagging: A sample-multiplexed high throughput assay for 25-hydroxyvitamin D2 and D3. Clin Chem (in press published online Jan. 18, 2011 as doi:10.1373/clinchem.2010.157115).
57. Weiskopf AS, Vouros P, Cunniff J, Binderup E, Björkling F, Binderup L, et al. Examination of structurally selective derivatization of vitamin D(3) analogues by electrospray mass spectrometry. J Mass Spectrom 2001;36:71-8.
58. Higashi T, Miura K, Kitahori J, Shimada K. Usefulness of derivatization in high-performance liquid chromatography/tandem mass spectrometry of conjugated vitamin D metabolites. Anal Sci 1999;15:619-23.
59. Higashi T, Shimada K. Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography-mass spectrometry. Anal Bioanal Chem 2004;378:875-82.
60. Higashi T, Shimada K, Toyo'oka T. Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1654-61.
61. Cookson RC, Gupte SS, Stevens IDR, Watts CT. 4-phenyl-1,2,4-triazoline-3,5-dione. Org Synth 1971;51:121.
62. Ikonomou MG, Blades AT, Kebarle P. Investigations of the electrospray interface for liquid chromatography/mass spectrometry. Anal Chem 1990;62:957-67.
63. Kebarle P, Tang L. From ions in solution to ions in the gas phase - the mechanism of electrospray mass spectrometry. Anal Chem 1993;65:972A-986A.
64. Tang L, Kebarle P. Dependence of ion intensity in electrospray mass spectrometry on the concentration of the analytes in the electrosprayed solution. Anal Chem 1993;65:3654-68.
65. Buhrman DL, Price PI, Rudewicz PJ. Quantitation of SR 27417 in human plasma using electrospray liquid chromatography-tandem mass spectrometry: A study of ion suppression. J Am Soc Mass Spectrom 1996;7:1099-105.
66. Jessome LL, Volmer DA. Ion suppression: a major concern in mass spectrometry. LCGC North America 2006;24:498-510.
67. Remane D, Wissenbach DK, Meyer MR, Maurer HH. Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotopelabeled internal standards by their native analogues using atmospheric-pressure chemical ionization and electrospray ionization and the relevance for multianalyte liquid chromatographic/mass spectrometric procedures. Rapid Commun Mass Spectrom 2010;24:859-67.
68. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:2198-207.
69. Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem 2010;56:1234-44.
70. Gosetti F, Mazzucco E, Zampieri D, Gennaro MC. Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. J Chromatogr A 2010;1217:3929-37.
71. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;75:3019-30.
72. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041-4.
73. Lien G-W, Chen C-Y, Wang G-S. Comparison of electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization for determining estrogenic chemicals in water by liquid chromatography tandem mass spectrometry with chemical derivatizations. J Chromatogr A 2009;1216:956-66.
74. Higashi T, Shimada K. Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography-mass spectrometry. Anal Bioanal Chem 2004;378:875-82.
75. Santa T, Al-Dirbashi OY, Fukushima T. Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry for biomedical analysis. Drug Discovery and Therapeutics 2007;1: 108-18.
76. Kumar V, Barnidge DR, Chen L-S, Twentyman JM, Cradic KW, Grebe SK, et al. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem 2010;56:306-13.
77. Page JS, Kelly RT, Tang K, Smith RD. Ionization and transmission efficiency in an electrospray ionizationmass spectrometry interface. J Am Soc Mass Spectrom 2007;18:1582-90.
78. Gangl ET, Annan MM, Spooner N, Vouros P. Reduction of signal suppression effects in ESI-MS using a nanosplitting device. Anal Chem 2001;73:5635-44.
79. Smith RD, Shen Y, Tang K. Ultrasensitive and quantitative analyses from combined separations-mass spectrometry for the characterization of proteomes. Acc Chem Res 2004;37:269-78.
80. Rice SL, Hale RC. Parameters for ultra-performance liquid chromatographic/tandem mass spectrometric analysis of selected androgens versus estrogens in aqueous matrices. Anal Chem 2009;81:6716-24.
81. Momoh P, Fandino A, Aisawa E, Schlabach T, Miller K, Stafford G. iFunnel technology for enhanced sensitivity in tandem LC/MS. Agilent Technologies Technical Support Library - Technical Overview 2010:1-8.
82. Plumb RS. A new high sensitivity tandem quadrupole mass spectrometer for quantitative LC/MS/MS analysis of low exposure pharmaceuticals. J Vis Exp 2010. http://www.jove.com/index/Details.stp?ID=2266, doi: 10.3791/2266.
83. Brancia FL. Recent developments in ion-trap mass spectrometry and related technologies. Expert Rev Proteomics 2006;3:143-51.
84. Perry RH, Cooks RG, Noll RJ. Orbitrap mass spectrometry: instrumentation, ion motion and applications. Mass Spectrom Rev 2008;27:661-99.
85. Busch K. Space charge in mass spectrometry. Spectroscopy 2004;19:35-8.
86. Kushnir MM, Rockwood AL, Nelson GJ, Yue B, Urry FM. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin Biochem 2005;38:319-27.
87. ABSciex. High-resolution quant and qual - AB SCIEX TripleTOFTM 5600 System. http://www.absciex.com/m1images/All_PSM_Marketing/TripleTOF_5600/brochures/ABSCIEX_TripleTOF5600.pdf (Accessed 7 December 2010).
88. McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, et al. SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem 2008;54: 53-60.
89. Doumas BT, Peters T Jr. Origins of dye-binding methods for measuring serum albumin. Clin Chem 2009;55: 583-4.
90. Sviridov D, Drake SK, Hortin GL. Reactivity of urinary albumin (microalbumin) assays with fragmented or modified albumin. Clin Chem 2008;54:61-8.
91. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009;55:24-38.
92. Babic N, Larson TS, Grebe SK, Turner ST, Kumar R, Singh RJ. Application of liquid chromatographymass spectrometry technology for early detection of microalbuminuria in patients with kidney disease. Clin Chem 2006;52:2155-7.
93. D'Amour P, Brossard J-H, Rousseau L, Nguyen-Yamamoto L, Nassif E, Lazure C, et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int 2005;68:998-1007.
94. Cantor T. Parathyroid hormone assay drift: an unappreciated problem in dialysis patient management. Semin Dial 2005;18:359-64.
95. Bruton J, Singh RJ, Grebe SK, Ladwig P, Barnidge D. Sensitive and rapid determination of Angiotensin I utilizing on-line extraction and LC-MS/MS [Abstract D-64]. Clin Chem 2007;53(Suppl):A180-A181.
96. Bystrom CE, Salameh W, Reitz R, Clarke NJ. Plasma renin activity by LC-MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity. Clin Chem 2010;56:1561-9.
97. Grebe SK. Diagnosis and managment of thyroid carcinoma: a focus on serum thyroglobulin. Expert Rev Endocrinol Metab 2009;4:25-43.
98. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 2008;54:1796-1804.
99. Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 2007;92:82-7.
100. Clarke NJ, Zhang Y, Salameh WA, Reitz RE. Serum thyroglobulin measurement by LC-MSMS in the presence of autoantibodies [Abstract]. Endocr Rev 2010;31(Suppl 1):S1673.